Overcoming Preexisting Humoral Immunity to AAV Using Capsid DecoysFederico Mingozzi, Katherine A. High, Carolann Howard et al.|Science Translational Medicine|2013Cited by 346
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cellsAshley T. Martino, Roland W. Herzog, Etiena Basner‐Tschakarjan et al.|Blood|2013Cited by 160
AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypesDaniel J. Hui, Etiena Basner‐Tschakarjan, Shyrie C Edmonson et al.|Molecular Therapy — Methods & Clinical Development|2015Cited by 83
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopesDaniel J. Hui, Federico Mingozzi, Etiena Basner‐Tschakarjan et al.|Molecular Therapy|2013Cited by 45
Peptide-Induced Antigen-Specific CD4+CD25+FoxP3+ T Cells Suppress Cytotoxicity T Cell Responses Directed Against the AAV Capsid.Daniel J. Hui, Federico Mingozzi, Etiena Basner‐Tschakarjan et al.|Blood|2010Cited by 2